Squadron Capital Management »

Bioage Labs shares owned by Squadron Capital Management

Quarter-by-quarter ownership of Bioage Labs (BIOA) shares owned by Squadron Capital Management from 13F filings

Historical chart of Squadron Capital Management investment in Bioage Labs

Tip: Access up to 7 years of quarterly data

All positions including Bioage Labs held by Squadron Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioage Labs by Squadron Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.9M 405k 24.51

More positions owned by Squadron Capital Management

Relmada Therapeutics (RLMD)
C4 Therapeutics Com Stk (CCCC)
Cogent Biosciences (COGT)
Zentalis Pharmaceuticals Call Option (ZNTL)
Kodiak Sciences (KOD)
Relay Therapeutics (RLAY)
Edgewise Therapeutics (EWTX)
Maze Therapeatics (MAZE)
Bioage Labs Call Option (BIOA)
Inventiva Sa Ads (IVA)
Adlai Nortye Sponsored Ads (ANL)
Compass Pathways Sponsored Ads (CMPS)
Enliven Therapeutics (ELVN)
Rezolute Com New (RZLT)
Arrivent Biopharma Call Option (AVBP)

View all positions for Squadron Capital Management

Top funds holding Bioage Labs

AH Capital Management
Cormorant Asset Management
Sofinnova Ventures
BlackRock
Jupiter Topco
Henderson Group
Octagon Capital Advisors
RA Capital Management
Vanguard Capital Management
Balyasny Asset Management
Polar Capital Holdings
Braidwell
State Street Corporation
Sands Capital Ventures
Geode Capital Management

View all funds holding Bioage Labs